Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Dare to be Different: Revamping Collaboration in Life Sciences Contract Manufacturing

1 608 vues

Publié le

Contract Manufacturing Organizations expansion has made the supply chain harder to manage for both life sciences companies and contract suppliers. Advanced digital technologies can enable a new era of supply chain collaboration. Visit https://accntu.re/2UVVP9F to learn more.

Publié dans : Technologie
  • Soyez le premier à commenter

  • Soyez le premier à aimer ceci

Dare to be Different: Revamping Collaboration in Life Sciences Contract Manufacturing

  1. 1. Patient Inspired. Outcomes Driven. DARETOBE DIFFERENT Revamping collaboration in life sciences contract manufacturing
  2. 2. The life sciences industry is transitioning as it shifts toward complex biopharmaceuticals and highly personalized medical therapies and devices. Copyright © 2019 Accenture. All rights reserved. 2 this shift is driving more complexity in supply chain operations. AS A RESULT,
  3. 3. How are brand owners and CMOs addressing the complexity? Copyright © 2019 Accenture. All rights reserved. 3 Accenture surveyed senior executives from various functions across 105 pharmaceutical, medical device and contract manufacturing companies to identify the challenges and find out more about how they plan to address today’s supply chain challenges. HOW WILL THEY DARE TO BE DIFFERENT?
  4. 4. of manufacturers plan to expand use of CMOs Externalized manufacturing will keep expanding Copyright © 2019 Accenture. All rights reserved. 4 of CMOs plans to increase capacity91% 78% NEXT 3 YEARS: One in five brand owners now work with over 100 external partners Companies are lacking visibility, control, and standardization
  5. 5. Biopharma companies plan to take advantage of CMO capacity expansion across multiple new science therapeutic areas Copyright © 2019 Accenture. All rights reserved. 5 CMO areas of expansion within the next 3 years: Currently leveraging Planning to leverage in the next 3 years API Production79% Packaging71% Formulation67% Development67% Brand Owner Usage of CMOs
  6. 6. The medical device industry will continue to grow CMO capacity to build smart devices Copyright © 2019 Accenture. All rights reserved. 6 CMO areas of expansion within the next 3 years: Currently leveraging Planning to leverage in the next 3 years Diabetes86% Diagnostics71% Cardiology, Orthopedics, Radiology57% Imaging, Surgery, Nephrology43% Pediatrics, Respiratory, Dental, Vision29% Neurotechnology14% Brand Owner Usage of CMOs
  7. 7. Where is the pressure coming from? Copyright © 2019 Accenture. All rights reserved. 7 LACK OF standardization and capabilities across large number of CMOs, increasing operational complexity and costs DISPARATE planning and execution slows decision making, leading to supply shortages & increased inventory LACK OF real-time visibility to manufacturing operations, leading to higher supply chain cost DELAYS in tech transfers and supplier on-boarding, reducing speed to market REDUCED product quality due to poor data integrity and latency of information exchange
  8. 8. Where does better CMO and brand owner collaboration start? Copyright © 2019 Accenture. All rights reserved. 8 PRODUCT DEVELOPMENT Both plan to improve their product development processes. QUALITY MANAGEMENT Both want to improve collaboration within their quality management processes. MANUFACTURING Brand Owners have limited visibility and control over CMO product manufacturing and quality. PRODUCT SUPPLY CHAIN PLANNING AND CAPACITY MANAGEMENT CMO’s and Brand Owners want to plan and manage their supply chains more proactively. TECH TRANSFERS This is the key challenge for CMO’s working with pharma companies.
  9. 9. Brand owners and CMOs expect digital technology to improve collaboration Copyright © 2019 Accenture. All rights reserved. 9 BRAND OWNERS CMOs Currently using Planning to implement in the next 3 years Currently using Planning to implement in the next 3 years
  10. 10. EMBRACE A NEW ERA OF CMO COLLABORATION Where to start: A four-step approach to rethink external manufacturing collaboration Copyright © 2019 Accenture. All rights reserved. 10 Identify sponsor and define business case 01 Define collaborative roadmap to pilot, then scale Co-invest with partners on strategic innovation Monitor performance and enhance 02 04 03
  11. 11. 11 Copyright © 2018 Accenture. All rights reserved. Linkedin.com/company/ Accenture_life_sciences @AccentureLifSci www.Accenture.com/ lifesciencesblog Click here to learn more and access the full report Visit and bookmark these links to stay up-to-date with Accenture Life Sciences Accenture.com/ContractManufacturing

×